[HTML][HTML] Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility
Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from
China all over the world and many COVID-19 outbreaks have been reported in long-term care …
China all over the world and many COVID-19 outbreaks have been reported in long-term care …
[HTML][HTML] Efficacy of cefiderocol-vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant …
…, C Borrazzo, A Quirino, R Lionello, F Serapide… - International journal of …, 2023 - Elsevier
Introduction Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae …
…, E Biamonte, R Lionello, F Serapide… - Journal of …, 2019 - academic.oup.com
Sir, Cefiderocol is a new siderophore cephalosporin, with potent activity against MDR Gram-negative
bacilli. It is particularly active against XDR Acinetobacter baumannii (Ab) infections, …
bacilli. It is particularly active against XDR Acinetobacter baumannii (Ab) infections, …
[HTML][HTML] Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia
M Mazzitelli, E Arrighi, F Serapide… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, Di Giambenedetto et al. 1 described their experience with intravenous tocilizumab
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study
…, E Arrighi, G Perri, F Serapide… - Therapeutic …, 2020 - journals.sagepub.com
The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …
[HTML][HTML] Is the pendulum of antimicrobial drug resistance swinging back after COVID-19?
F Serapide, A Quirino, V Scaglione, HL Morrone… - Microorganisms, 2022 - mdpi.com
The COVID-19 pandemic may have had an effect on antimicrobial resistance. We compared
the prevalence of ESKAPE multidrug-resistant (MDR) bacterial infections in COVID-19 …
the prevalence of ESKAPE multidrug-resistant (MDR) bacterial infections in COVID-19 …
Prevalence of antibiotic resistance over time in a third-level University Hospital
…, M Reale, C Davoli, M Mazzitelli, F Serapide… - Microbial Drug …, 2022 - liebertpub.com
This study evaluated the spread and possible changes in resistance patterns of ESKAPE
bacteria to first-choice antibiotics from 2015 to 2019 at a third-level university hospital after …
bacteria to first-choice antibiotics from 2015 to 2019 at a third-level university hospital after …
[HTML][HTML] Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study
…, L Berardelli, A Quirino, V Olivadese, F Serapide… - BMC Infectious …, 2022 - Springer
Background Monoclonal antibodies (mAbs) and antivirals have been approved for early therapy
of coronavirus disease (COVID-19), however, in the real-life setting, there are difficulties …
of coronavirus disease (COVID-19), however, in the real-life setting, there are difficulties …
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff
…, A Bruni, EM Trecarichi, F Serapide… - Medico-Legal …, 2021 - journals.sagepub.com
The activity of the SARS-CoV-2 virus has not yet been studied in a post-mortem setting. The
absence of these data has led to the prohibition of exposure of infected corpses during …
absence of these data has led to the prohibition of exposure of infected corpses during …
[HTML][HTML] Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: A single-centre real-world experience
…, M Mazzitelli, E Garofalo, F Divenuto, F Serapide… - BMC Infectious …, 2022 - Springer
Background T2Dx was approved by the US Food and Drug Administration for the rapid detection
of a modified panel of ESKAPE bacterial species or Candida spp. causing bloodstream …
of a modified panel of ESKAPE bacterial species or Candida spp. causing bloodstream …